Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
michael.zimmermann@rdm.ox.ac.uk

Research groups

Michael Bruce Zimmermann

Professor of Human Nutrition

I received my M.D. from the Vanderbilt University School of Medicine, and did postgraduate medical training at the University of California in San Francisco and Berkeley. From 2012-2022, I was Professor of Human Nutrition at the ETH Zurich in Switzerland. From 2006-2011, I was Professor of Micronutrients and International Health at Wageningen University in the Netherlands. I am a Guest Professor in the Endocrinology and Diabetes Section at the Hospital of the University of Zurich, current Chair of the Iodine Global Network, an international NGO, and was a Web of Science Highly Cited Researcher (Top 1%) 2017-2024. My research interests include iron metabolism, biomarkers and interventions, nanotechnology, and iron stable isotopes as tracers in human studies.

Key publications

Iron Deficiency Anemia at Time of Vaccination Predicts Decreased Vaccine Response and Iron Supplementation at Time of Vaccination Increases Humoral Vaccine Response: A Birth Cohort Study and a Randomized Trial Follow-Up Study in Kenyan Infants.

Stoffel NU. et al, (2020), Front Immunol, 11

A heat-stable microparticle platform for oral micronutrient delivery.

Anselmo AC. et al, (2019), Sci Transl Med, 11

An intensified training schedule in recreational male runners is associated with increases in erythropoiesis and inflammation and a net reduction in plasma hepcidin.

Moretti D. et al, (2018), Am J Clin Nutr, 108, 1324 - 1333

Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials.

Stoffel NU. et al, (2017), Lancet Haematol, 4, e524 - e533

Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants.

Jaeggi T. et al, (2015), Gut, 64, 731 - 742

Iodine deficiency and thyroid disorders.

Zimmermann MB. and Boelaert K., (2015), Lancet Diabetes Endocrinol, 3, 286 - 295

Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double-blind, randomised, placebo-controlled trial.

Bouhouch RR. et al, (2014), Lancet Diabetes Endocrinol, 2, 197 - 209

Afebrile Plasmodium falciparum parasitemia decreases absorption of fortification iron but does not affect systemic iron utilization: a double stable-isotope study in young Beninese women.

Cercamondi CI. et al, (2010), Am J Clin Nutr, 92, 1385 - 1392

Iron from nanocompounds containing iron and zinc is highly bioavailable in rats without tissue accumulation.

Hilty FM. et al, (2010), Nat Nanotechnol, 5, 374 - 380

Nutritional iron deficiency.

Zimmermann MB. and Hurrell RF., (2007), Lancet, 370, 511 - 520

More publications